Metastatic Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Metastases ? the real cancer risk | Science| In-depth reporting on ... - Deutsche Welle



Deutsche Welle
 
Metastases ? the real cancer risk | Science| In-depth reporting on ... 
Deutsche Welle
Metastases are often more dangerous than the primary tumor that gives rise to them. They are responsible for 90% of all cancer deaths. Here are the most important facts on these deadly 'sleeper' tumors.

and more » 


Erica's Cancer Journey: Metastatic breast cancer, an acrostic - Hudson Valley One



Hudson Valley One
 
Erica's Cancer Journey: Metastatic breast cancer, an acrostic 
Hudson Valley One
A Amy Schumer, one of my favorite comedians, brings her game to the edge and keeps it real, encouraging me to do the same. T Treating myself to a milkshake or a totebag cheers me up when I'm faced with cancer progression or a difficult treatment. I'm ...

 


How one enzyme could stop the spread of cancer - Medical News Today



Medical News Today
 
How one enzyme could stop the spread of cancer 
Medical News Today
A study reveals that activation of the enzyme RIPK1 can trigger cell death in cancer cells poised to migrate by causing them to degrade their mitochondria.

and more » 


Molecular Trojan horse delivers chemotherapeutic drug to cancer cells - Science Daily



Science Daily
 
Molecular Trojan horse delivers chemotherapeutic drug to cancer cells 
Science Daily
EphA2 spreads cancer by allowing malignant cells to migrate from the primary tumor into circulation and eventually to adhere to other tissues. "Once this novel tumor-homing agent binds to the EphA2 receptor, the oncogene functions as a cancer-specific ...

and more » 


FOLFOXIRI plus cetuximab active, feasible for metastatic colorectal cancer - Healio



FOLFOXIRI plus cetuximab active, feasible for metastatic colorectal cancer 
Healio
A 4-month course of induction therapy with modified FOLFOXIRI and cetuximab produced significant activity and appeared feasible for patients with RAS and BRAF wild-type metastatic colorectal cancer, according to researchers in Italy. ?The triplet ...

 


Mini lab-created organs successfully check cancer treatments - Axios - Axios



Axios
 
Mini lab-created organs successfully check cancer treatments - Axios 
Axios
Lab-grown tumor tissue matched response of the patient's tumor to cancer treatment.
'Mini-tumours' created to battle cancer - BBC News BBC News
Testing cancer drugs on mini tumours The Hippocratic Post (blog)

all 10 news articles » 


Abemaciclib for HR-Positive Metastatic Breast Cancer - OncLive - OncLive



OncLive
 
Abemaciclib for HR-Positive Metastatic Breast Cancer - OncLive 
OncLive
Adam M. Brufsky, MD, PhD, FACP; Komal Jhaveri, MD, FACP; Lee Schwartzberg, MD, FACP; Hope S. Rugo, MD; and Francisco Esteva, MD, PhD, discuss the use of abemaciclib in metastatic hormone receptor-positive breast cancer, the management of toxicity, and ...

and more » 


Immunotherapy for Metastatic Melanoma ? In the Clinic - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Immunotherapy for Metastatic Melanoma ? In the Clinic 
Cancer Therapy Advisor
While the primary treatment for melanoma is surgical excision, patients with metastatic disease require additional therapy; immunotherapy is an innovative class of medications accumulating data for use in this patient-group. In melanoma, the immune ...

 


Big step toward stopping cancer metastasis: New research uncovers ... - Science Daily



Science Daily
 
Big step toward stopping cancer metastasis: New research uncovers ... 
Science Daily
New research may give scientists a chance to target tumors before they metastasize. The study shows that a protein called LTBP3 fuels a chain reaction that leads some early developing tumors to grow new blood vessels. These vessels then act like ...
Scientists take big step toward stopping cancer metastasis Medical Xpress

all 1 news articles » 


Tumor Organoids Predict How Well Patients Respond to Cancer Drugs - The Scientist



The Scientist
 
Tumor Organoids Predict How Well Patients Respond to Cancer Drugs 
The Scientist
He and his colleagues collected 110 biopsies of metastatic tumors from 71 patients with gastroesophageal or colorectal cancers. Approximately 70 percent of the tumors were successfully grown into organoids. Comparing the genetic mutations and protein ...